Novotech Releases Comprehensive Report on Oncolytic Virus Therapy
Explore the latest insights into global clinical trial trends, innovations, and strategies shaping the future of oncolytic virus therapy.
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, has released its latest report, Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into this transformative approach to cancer treatment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122884484/en/
Oncolytic virus therapies utilize genetically modified or naturally occurring viruses to selectively target tumor cells and stimulate immune responses. This dual mechanism is creating new possibilities in oncology and other therapeutic areas.
Key Highlights:
- Global Trial Landscape: Asia-Pacific leads with 40% of OVT clinical trials, followed closely by North America and Europe, reflecting a global focus on advancing these therapies.
- Pipeline Insights: Solid tumors dominate OVT research, with trials targeting cancers such as melanoma, glioblastoma, and pancreatic cancer.
- Innovative Delivery Systems: Advances like nanoparticle systems and cell-based carriers address key challenges in targeting and delivery.
- Combination Therapies: Integration with immune checkpoint inhibitors, CAR-T therapies, and chemotherapy is enhancing the efficacy and scope of OVT.
- Regulatory Overview: Provides guidance on navigating complex global regulatory pathways, including insights into fast-tracking approvals.
This complimentary report offers biotech and pharmaceutical companies, data-driven analysis to navigate the complexities of clinical trials and regulatory frameworks in oncolytic virus therapy.
About NovotechNovotech-CRO.com
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech and small to mid-size companies to accelerate the development of advanced and novel therapeutics at every phase.
Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Fierce CRO 2024 Excellence Award in Clinical Trial Management and Global Operations, Frost & Sullivan 2024 Global Biotech CRO of the year award, Clinical Trials Arena 2024 Excellence Awards in Business Expansion, Innovation and Marketing, 2024 Employer of Choice, 2024 Great Place to Work in the US, 2024 Brandon Hall Gold Award, CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.
The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.
For more information or to speak to an expert team member visit www.Novotech-CRO.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122884484/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rimini Street Announces Rimini Protect™ Advanced Hypervisor Security for VMware, Nutanix and All Other Linux-Based Hypervisors, Powered by Vali Cyber®, to Safeguard Against Ransomware and Other Vulnerabilities22.1.2025 15:00:00 CET | Press release
Rimini Protect Advanced Hypervisor Security is embedded into the industry-leading Rimini Support™ for VMware solution that replaces VMware annual maintenance at substantial savings and extends the supportable lifespan of existing VMware licenses for many years Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, the leading third-party support provider for Oracle, SAP and VMware software, today announced the general availability of Rimini Protect™ Advanced Hypervisor Security (AHS), an exclusive solution powered by proven Vali Cyber® AI/ML security technology. The Rimini Protect AHS solution leverages these innovative capabilities that are already protecting mission-critical hypervisor infrastructure, including US military VMware deployments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122401764/en/ Rimini Street Announces Rimini Protect™ Advanced Hyp
Qualcomm Schedules First Quarter Fiscal 2025 Earnings Release and Conference Call22.1.2025 15:00:00 CET | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company’s financial results for its first quarter fiscal 2025 on Wednesday, February 5, 2025, after the close of the market on the Company’s Investor Relations website, at https://investor.qualcomm.com/financial-information. The earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K, which will be available on the SEC website at http://www.sec.gov. Qualcomm will host a conference call to discuss its first quarter fiscal 2025 results which will be broadcast live on February 5, 2025, beginning at 1:45 p.m. Pacific Time (PT) at https://investor.qualcomm.com/news-events/investor-events/default.aspx. An audio replay will be available at https://investor.qualcomm.com/news-events/investor-events/default.aspx and via telephone following the live call for 30 days thereafter. To listen to the replay via telephone, U.S. callers may dial (877) 660-6853 and international call
Improbable Leverages Improved Financial Profile to Drive Innovation in AI, the Metaverse, and Web3 Through Venture Building22.1.2025 14:00:00 CET | Press release
Predictions for 2025 Signal a Breakthrough Year for Virtual Economies, Interoperable Identities, and AI-Powered Gaming Improbable, a venture builder dedicated to growing businesses across AI, the metaverse, and Web3 ecosystems, has capped off a transformative 2024 with the announcement of the profitability threshold achieved in the previous financial year, a change in business model, and significant progress across interconnected ecosystems. Central to its success is the company’s venture-building model, which has proven instrumental in creating businesses and technologies that shape the future of virtual worlds and digital economies. Venture Building: Driving Innovation Across Ecosystems and Building the Open Metaverse Improbable’s venture-building strategy has been key to addressing challenges and unlocking opportunities across frontier ecosystems. In 2024, the company launched several new ventures, including: Kallikor, an AI-powered platform accelerating the adoption of robotics in
WEF25: Saudi Foreign Minister Says Middle East Has “Opportunity to Turn a Page” Following Gaza Ceasefire22.1.2025 13:25:00 CET | Press release
Saudi Arabia’s Minister of Foreign Affairs, His Highness Prince Faisal bin Farhan bin Abdullah, today said the Middle East has an opportunity to shape a prosperous future following the Gaza ceasefire deal which came into effect at the start of the week. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250121797711/en/ Saudi Arabia’s Minister of Foreign Affairs, His Highness Prince Faisal bin Farhan bin Abdullah, addressed a panel session at the World Economic Forum Annual Meeting 2025 in Davos on ‘Diplomacy amid Disorder’, where he spoke about an opportunity for the region “to turn a page” (Photo: AETOSWire) “We are certainly in a region that is abundant with risk factors. But we are also in a region that has huge potential. Even with a very difficult year behind us, we have shown we can be resilient as a region and we can look to the future, whether it’s the Kingdom, the GCC countries and their ability to stay on track with t
World-Class Supply Chain Leaders Confirmed for Kinexions 202522.1.2025 13:00:00 CET | Press release
ExxonMobil, Eaton, Volvo, Colgate-Palmolive, Hershey and more among confirmed line-up for the Kinaxis community conference in Austin, Texas Renowned global brands ExxonMobil, Eaton, Volvo, Colgate-Palmolive and Hershey are just some of the confirmed participants for Kinexions 2025, hosted by Kinaxis®(TSX:KXS), a global leader in end-to-end supply chain orchestration. Taking place from March 31 to April 2, this year’s event is shaping up to be the biggest and best ever, with hundreds of supply chain experts, leaders and innovators. The three-day event will feature: a mainstage keynote address from Staale Gjervik, president supply chain at ExxonMobil who will share insights into how the largest integrated energy company is pioneering enterprise-wide orchestration, the story behind biopharmaceutical leader Merck & Co.’stransformation to serve patients with greater speed and accuracy, the secrets behind Hershey’s groundbreaking supply chain journey, building a greener future with Schneider
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom